Anixa Biosciences (ANIX) Receivables (2012 - 2026)
Anixa Biosciences (ANIX) posted Receivables of $56,000 for fiscal Q2 2026 (quarter ended Apr 30, 2026).
Powered by 
Analysis
Anixa Biosciences (ANIX) Receivables (2012 - 2026) Analysis & Trends
At the end of FY2024 (ended Oct 31, 2024), Anixa Biosciences' Receivables came in at $173,000, down 35.9% from FY2023.
- Annual Receivables shows a five-year compound annual growth rate of 21.1% (FY2019 to FY2024).
- In prior fiscal years, Anixa Biosciences' Receivables was $270,000 in FY2023 (+487.0%), $46,000 in FY2022 and $2,231 in FY2020 (-96.6%).
- The fiscal Q2 2026 figure stands as the highest quarterly Receivables since fiscal Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 23.48 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 13.82 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 15.68 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 5.06 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 12.49 Bn |
| 10 | Anixa Biosciences | 96.15 Mn | 81.01 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 56,000.00 |
| Oct 31, 2024 | 173,000.00 |
| Jul 31, 2024 | 410,000.00 |
| Apr 30, 2024 | 218,000.00 |
| Jan 31, 2024 | 391,000.00 |
| Oct 31, 2023 | 270,000.00 |
| Jul 31, 2023 | 334,000.00 |
| Apr 30, 2023 | 256,000.00 |
| Jan 31, 2023 | 147,000.00 |
| Oct 31, 2022 | 46,000.00 |
| Oct 31, 2020 | 2,231.00 |
| Jul 31, 2020 | 5,950.00 |
| Apr 30, 2020 | 32,338.00 |
| Jan 31, 2020 | 22,311.00 |
| Oct 31, 2019 | 66,527.00 |
| Jul 31, 2019 | 1,072.00 |
| Apr 30, 2019 | 796,954.00 |
| Oct 31, 2018 | 306,991.00 |
| Jul 31, 2017 | 221,049.00 |
| Jan 31, 2015 | 45,000.00 |
API Access
Anixa Biosciences Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();